These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 15654771)

  • 1. Evidence-based medicine in practice: applying intention-to-treat analysis and perprotocol analysis.
    Schoenfeld PS
    Am J Gastroenterol; 2005 Jan; 100(1):3-4. PubMed ID: 15654771
    [No Abstract]   [Full Text] [Related]  

  • 2. Irritable bowel syndrome: a mild disorder; purely symptomatic treatment.
    Prescrire Int; 2009 Apr; 18(100):75-9. PubMed ID: 19585728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effectiveness of pharmacotherapy of irritated bowel syndrome from the standpoint of evidence based medicine].
    Sheptulin AA; Vize-Khripunova MA
    Klin Med (Mosk); 2014; 92(7):64-8. PubMed ID: 25775909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical trial: the effect of amitriptyline in patients with diarrhoea-predominant irritable bowel syndrome.
    Vahedi H; Merat S; Momtahen S; Kazzazi AS; Ghaffari N; Olfati G; Malekzadeh R
    Aliment Pharmacol Ther; 2008 Apr; 27(8):678-84. PubMed ID: 18248658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double-blind placebo-controlled trial of amitriptyline for the treatment of irritable bowel syndrome in adolescents.
    Bahar RJ; Collins BS; Steinmetz B; Ament ME
    J Pediatr; 2008 May; 152(5):685-9. PubMed ID: 18410774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence that amitriptyline may be effective in treating diarrhea-predominant irritable bowel syndrome.
    Lundberg GD
    Medscape J Med; 2008 Jun; 10(6):132. PubMed ID: 18679541
    [No Abstract]   [Full Text] [Related]  

  • 7. Efficacy of current drug therapies in irritable bowel syndrome: what works and does not work.
    Schoenfeld P
    Gastroenterol Clin North Am; 2005 Jun; 34(2):319-35, viii. PubMed ID: 15862938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and tolerability of alosetron for the treatment of irritable bowel syndrome in women and men: a meta-analysis of eight randomized, placebo-controlled, 12-week trials.
    Rahimi R; Nikfar S; Abdollahi M
    Clin Ther; 2008 May; 30(5):884-901. PubMed ID: 18555935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of dioctahedral smectite in treating patients of diarrhea-predominant irritable bowel syndrome.
    Chang FY; Lu CL; Chen CY; Luo JC
    J Gastroenterol Hepatol; 2007 Dec; 22(12):2266-72. PubMed ID: 17559369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tong-xie-ning, a Chinese herbal formula, in treatment of diarrhea-predominant irritable bowel syndrome: a prospective, randomized, double-blind, placebo-controlled trial.
    Wang G; Li TQ; Wang L; Xia Q; Chang J; Zhang Y; Wan MH; Guo J; Cheng Y; Huang X; Zhang RM
    Chin Med J (Engl); 2006 Dec; 119(24):2114-9. PubMed ID: 17199964
    [No Abstract]   [Full Text] [Related]  

  • 11. [Tegaserod in treatment of women with irritable bowel syndrome].
    Munck LK; Ainsworth MA
    Ugeskr Laeger; 2007 Jun; 169(23):2190-2. PubMed ID: 17592683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of diarrhea-predominant irritable bowel syndrome with traditional Chinese herbal medicine: a randomized placebo-controlled trial.
    Leung WK; Wu JC; Liang SM; Chan LS; Chan FK; Xie H; Fung SS; Hui AJ; Wong VW; Che CT; Sung JJ
    Am J Gastroenterol; 2006 Jul; 101(7):1574-80. PubMed ID: 16863563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expert commentary--evidence-based guidelines for the treatment of irritable bowel syndrome in North America.
    Schoenfeld P;
    MedGenMed; 2003 Apr; 5(2):13. PubMed ID: 14603112
    [No Abstract]   [Full Text] [Related]  

  • 14. How do you spell relief for irritable bowel syndrome?
    Moynihan NT; Callahan MJ; Kalsmith B; Moses PL
    J Fam Pract; 2008 Feb; 57(2):100-8. PubMed ID: 18248730
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy of probiotics in irritable bowel syndrome: a meta-analysis of randomized, controlled trials.
    Nikfar S; Rahimi R; Rahimi F; Derakhshani S; Abdollahi M
    Dis Colon Rectum; 2008 Dec; 51(12):1775-80. PubMed ID: 18465170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The use of bismuth tripotassium dicitrate (De-Nol), a promising line of pathogenetic therapy for irritated bowel syndrome with diarrhea].
    Iakovenko EP; Agafonova NA; Pokhal'skaia OIu; Kolganova AV; Nazarbekova RS; Ivanov AN; Davletshina IV; Popova EV; Prianishnikova AS; Ovchinnikova NI; Iakovenko AV; Aldiiarova MA; D'iachkoava AV; Gioeva IZ
    Klin Med (Mosk); 2008; 86(10):47-52. PubMed ID: 19069460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cilansetron in the treatment of diarrhea-predominant irritable bowel syndrome?
    Stacher G
    Expert Rev Gastroenterol Hepatol; 2007 Oct; 1(1):15-27. PubMed ID: 19072430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A dose-ranging, phase II study of the efficacy and safety of alosetron in men with diarrhea-predominant IBS.
    Chang L; Ameen VZ; Dukes GE; McSorley DJ; Carter EG; Mayer EA
    Am J Gastroenterol; 2005 Jan; 100(1):115-23. PubMed ID: 15654790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of loperamide in gastrointestinal disorders.
    Hanauer SB
    Rev Gastroenterol Disord; 2008; 8(1):15-20. PubMed ID: 18477966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Symptomatic efficacy of beidellitic montmorillonite in irritable bowel syndrome: a randomized, controlled trial.
    Ducrotte P; Dapoigny M; Bonaz B; Siproudhis L
    Aliment Pharmacol Ther; 2005 Feb; 21(4):435-44. PubMed ID: 15709995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.